Editor's Note
Some Additional Considerations Regarding the American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use
Tobacco Use Disorder
Specifying and Pilot Testing Quality Measures for the American Society of Addiction Medicine's Standards of Care
Abuse Potential of Oral Phendimetrazine in Cocaine-dependent Individuals
Effect of Lowering the Dose of Varenicline on Alcohol Self-administration in Drinkers With Alcohol Use Disorders
Strategic Versus Nonstrategic Gambling
Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder
AST
Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders
Reducing Problematic Benzodiazepine Use Among Individuals Enrolled in Methadone Treatment Programs
Stigmatizing and Misleading Terminology—More
Editor's response to Newman and Gevertz “Stigmatizing and Misleading Terminology—More”
Measuring Quality of Buprenorphine Care
Treatment Quality for Buprenorphine Care
Appreciation of Reviewers
Society News
2016 ASAM Annual Poster Presenter Abstracts